BioTrinity 2024, 23-24 April

New venue: Convene 133 Houndsditch, London

**Book Now - Rates Rise 31 March 2024**

BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers. 


After the sell-out success of BioTrinity 2023, OBN are pleased to announce the 2024 edition will be hosted in a larger capacity venue, Convene 133 Houndsditch in London.  The move will allow us to deliver an enhanced format, in a more spacious environment, whilst ensuring we continue to catalyse success for all who attend


Key changes for 2024 include:

  •  An increase in audience size of c.15%
  • More spacious partnering area
  • Three tracks of presentations; two science focused and one business/investment focused, with each track incorporating more breaks and added time for questions with speakers
  • Plenty of informal seating space for delegates to catch up on calls and take impromptu meetings
  • An all-delegate networking party on-site at the conference venue on Tuesday 23 April, included in the delegate ticket price

Additional conference features include:

  • Scientific spotlight presentations from Series A stage companies across Oncology, Lung, Kidney & GI, Neurodegenerative & Age related Diseases, Platforms for Drug Discovery, Immunology & Inflammation, Rare Diseases, Infectious Diseases, Medtech, Femtech, Cardiovascular & Metabolic Diseases and more
  • Two days of pre-scheduled in-person private partnering meetings and a bonus virtual third day
  • An enhanced sponsors exhibition 
  • Two-days of catering for all delegates, including the new all-delegate networking evening on Tuesday 23 April
  •  Access to digital content from the business track, and presentations from the scientific sessions

*We are pleased to confirm that delegates rates remain unchanged for 2024*